Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,758 across all filing types
Latest filing 2026-06-01 Environmental & Social …
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Business Responsibility and Sustainability Reporting (BRSR) for FY 2025-26
Environmental & Social Information Classification · 95% confidence The document is a Business Responsibility and Sustainability Report (BRSR) filed under SEBI’s Listing Regulations, containing comprehensive ESG disclosures (environmental, social and governance metrics), assurance statements, management disclosures, KPI performance against sustainability principles. It is not a full annual report or financial statements, nor an announcement of vote results or management change, but an ESG-focused statutory report. Therefore, it fits the Environmental & Social Information category.
2026-06-01 English
Submission of Annual Report for FY 2025-26 and intimation of voting through electronic means
Regulatory Filings
2026-06-01 English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a notice to stock exchanges (BSE and NSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015, providing the schedule of upcoming investor meetings. It does not contain financial results, report attachments, or proxy materials, but rather is a routine regulatory announcement of material events (investor meet schedule). This fits the fallback category for general regulatory filings and announcements.
2026-05-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 92% confidence The document is an exchange filing under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, providing an intimation of the schedule of investors’ meetings. It does not contain actual financial results or detailed presentations but is a routine compliance announcement to stock exchanges. Therefore, it falls under general regulatory announcements and compliance filings (Regulatory Filings).
2026-05-30 English
Newspaper Advertisement - Intimation of 53rd Annual General Meeting of the Company through VC/OAVM
Proxy Solicitation & Information Statement Classification · 80% confidence The document is a formal announcement and notice of the company’s 53rd Annual General Meeting (AGM), including e-voting instructions and details of the meeting resolutions. It is not the Annual Report itself, nor an earnings release, management change notice, or other category. It constitutes proxy solicitation materials (i.e., information sent to shareholders to inform them of the meeting and request their votes). Under the taxonomy, this corresponds to Proxy Solicitation & Information Statement (PSI).
2026-05-28 English
Copy of Newspaper Publication
Proxy Solicitation & Information Statement Classification · 68% confidence The document is the formal Notice of the 53rd Annual General Meeting published in the newspaper and sent to the stock exchanges and shareholders, including details on the AGM, e‐voting procedures, record date, and availability of the Integrated Annual Report. This constitutes materials sent to members to provide information about the meeting and to solicit votes (remote e‐voting and e‐voting during the AGM). Under our taxonomy, these are proxy solicitation/information statement materials rather than the meeting presentation itself or a simple report‐publication announcement.
2026-05-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.